Anavex Life Sciences Corp (AVXL)

[sokol]

Cures Act. See this website for a summary that I think is pertinent to AVXL 2-73:

https://multiplesclerosisnewstoday.com/2016/12/22/21st-century-cures-act-may-speed-approval-stem-cell-therapies-for-multiple-sclerosis/

This article mentions a definition for regenerative medicine and advanced therapies :

Under the Cures Act, “regenerative medicine and advanced therapies” are defined so as to include gene therapy, gene-modified cell therapy, therapeutic tissue engineering products, human cell and tissue products, and combination products that use these therapies or products, according to an “explainer” on the new law released by the Regulatory Affairs Professionals Society or RAPS.

What is that combination therapy Biogen is studying in combination with AVXL 2-73?